VANCOUVER, Washington, July 30, 2015 /PRNewswire/ --
ReportsnReports.com adds cancer diagnostics market 2015 research reports analyzing tumor biomarker tests, imaging, endoscopy and biopsy as well as providing forecasts for the global industry by technology and application.
The Global Cancer Diagnostics Industry (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Report 2015 spread across 207 pages, talking about 9 companies and supported with 180 tables and figures is now available at http://www.reportsnreports.com/reports/406389-global-cancer-diagnostics-tumor-biomarker-tests-imaging-endoscopy-and-biopsy-industry-report-2015.html .
This is a professional and in-depth study on the current state of the cancer diagnostics market covering Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Cancer Diagnostics market (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans of cancer diagnostics market are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The cancer diagnostics market (tumor biomarker tests, imaging, endoscopy and biopsy) development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 180 tables and figures to support this cancer diagnostic market analysis, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Companies like Pfizer, Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Genoptix, Inc., Eli Lilly and Company, bioMeriux SA, AstraZeneca PLC, Ambry Genetics and Abbott Laboratories, Inc. are profiled in this research report available for purchase at http://www.reportsnreports.com/Purchase.aspx?name=406389 .
The second research on Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020 says this market is expected to reach $13.1 Billion by 2020 from $7.1 Billion in 2015, and is poised to grow at a CAGR of 12.9% during the forecast period. The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms. Moreover, the market has seen the advent of hybrid imaging instruments with enhanced accuracy, such as PET/CT and SPECT/CT. These advancements have augmented the growth of the cancer diagnostics market. However, shortage of trained and skilled personnel poses as a restraint to the market growth of cancer diagnostics. Rise in aging population and increasing cancer cases are likely to create huge opportunity for cancer diagnostics.
The instrument-based cancer diagnostics segment accounted for the largest share of the global the cancer diagnostics market, by technology, while breast cancer accounted for the largest share of the cancer diagnostics applications market, in 2014. North America accounted for the largest share of the global cancer diagnostics market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the cancer diagnostics market is expected to experience the highest growth rate in the Asian region, with emphasis on India and China. These countries are expected to serve as revenue pockets for companies operating in the cancer diagnostics market.
Some of the major players in the global cancer diagnostics system market include Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (Denmark), Becton, Dickinson and Company (U.S.), GE Healthcare (U.K.), QIAGEN N.V. (Netherlands), Abbott Laboratories, Inc. (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Philips Healthcare (U.K.), and C.R. Bard, Inc. (U.S.), among others. Comprehensive table of contents and more on this cancer diagnostics market research is available at http://www.reportsnreports.com/reports/402128-cancer-diagnostics-market-by-technology-elisa-elfa-pcr-ngs-immunohistochemistry-microarray-imaging-mri-ct-pet-ultrasound-mammography-biopsy-application-breast-cancer-lung-cancer-colorectal-cancer-melanoma-forecast-to-2020.html .
For the cancer diagnostics market and its existing and prospective players, ReportsnReports.com has a range of newly published research reports:
2015 Strategic Assessments of Current and Emerging Cancer Diagnostics Market Players: The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Abbott, AdnaGen/Alere, Agilent Technologies, Applied Gene Technologies, Arca Biopharma, Beckman Coulter/Danaher, Becton Dickinson, Biomedical Diagnostics, bioMerieux, Bio-Rad, CellSearch, Cepheid, Correlogic Systems/Vermillion, Decode Genetics, Diadexus, Diagnocure, Diasorin, Eiken Chemical, Elitech Group, Epigenomics, Enterix, Enzo Biochem, Exact Sciences, Fujirebio, Guided Therapeutics, Hologic/Gen-Probe, Kreatech/Leica, Kyowa Medex, Mackay Life Sciences, Myriad Genetics, OncoLab, Ortho-Clinical Diagnostics, Panacea Pharmaceuticals, Polartechnics, Polymedco, PreMD, Qiagen, Quest Diagnostics, Radient Pharmaceuticals, Roche, Scienion, Sequenom, Siemens Healthcare, Takara Bio, Targeted Diagnostics & Therapeutics, Thermo Fisher, Tosoh, Veridex, Wako Pure Chemicals, Wallac/PE and Zila/Alere are the companies discussed in this research available at http://www.reportsnreports.com/reports/405506-2015-strategic-assessments-of-current-and-emerging-cancer-diagnostics-market-players.html .
2015-2019 Global Cancer Diagnostics Market: Country Segment Volumes and Sales Forecasts, Laboratory Universe: This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country. Worldwide, All Market Segments, Laboratories Performing Cancer Diagnostic Testing By Country; Worldwide, All Market Segments, Cancer Diagnostic Test Volume Forecasts By Country and Worldwide, All Market Segments, Cancer Diagnostics Sales Forecasts By Country are the three major tables provided in this research along with information on business environment, market structure, market size and growth. Complete report is available at http://www.reportsnreports.com/reports/405385-2015-2019-global-cancer-diagnostics-market-country-segment-volumes-and-sales-forecasts-laboratory-universe.html .
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Connect With Us on:
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
4400 NE 77th Avenue, Suite 275,
Vancouver, Washington 98662